doxorubicine liposomaal
Deadline:19 Mar 2024, 00:00 CET
Tender information
TED EUMechelen, Belgium
- Type
- 16
- Procedure
- open
- Ref. number
- 100459-2024
- CPV
- 33690000
doxorubicine liposomaal - anagrelide - gefitinib - bortezomib - bendamustine - etoposide
Mechelen, Belgium
doxorubicine liposomaal - anagrelide - gefitinib - bortezomib - bendamustine - etoposide